We are live on ! Find out more
MGLN

Magellan Health Services, Inc.

Delisted

MGLN was delisted on the 3rd of January, 2022.

204 hedge funds and large institutions have $1.53B invested in Magellan Health Services, Inc. in 2016 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 83 increasing their positions, 67 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

117% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 12

24% more repeat investments, than reductions

Existing positions increased: 83 | Existing positions reduced: 67

17% more call options, than puts

Call options by funds: $899K | Put options by funds: $770K

7% more funds holding

Funds holding: 191204 (+13)

4% less capital invested

Capital invested by funds: $1.59B → $1.53B (-$57.4M)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

Holders
204
Holders Change
+13
Holders Change %
+6.81%
% of All Funds
5.44%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.08%
New
26
Increased
83
Reduced
67
Closed
12
Calls
$899K
Puts
$770K
Net Calls
+$129K
Net Calls Change
-$1.67M
Name Holding Trade Value Shares
Change
Change in
Stake
SCP
76
Seizert Capital Partners
Michigan
$2.63M +$290K +4,305 +12%
Swiss National Bank
77
Swiss National Bank
Switzerland
$2.62M -$182K -2,700 -6%
New York State Common Retirement Fund
78
New York State Common Retirement Fund
New York
$2.61M +$92.2K +1,369 +4%
Robeco Institutional Asset Management
79
Robeco Institutional Asset Management
Netherlands
$2.58M
BG
80
BlackRock Group
United Kingdom
$2.58M -$189K -2,808 -7%
RhumbLine Advisers
81
RhumbLine Advisers
Massachusetts
$2.56M -$694K -10,307 -21%
MAM
82
Martingale Asset Management
Massachusetts
$2.51M -$20.2K -300 -0.8%
HI
83
HBK Investments
Texas
$2.44M +$2.5M +37,100 New
CEP
84
Chicago Equity Partners
Illinois
$2.36M +$561K +8,330 +30%
B
85
Bailard
California
$2.28M +$3.23K +48 +0.1%
VIA
86
Vident Investment Advisory
Georgia
$2.25M -$2.23M -33,072 -49%
O
87
OppenheimerFunds
New York
$2.22M +$224K +3,325 +11%
Canada Life
88
Canada Life
Manitoba, Canada
$2.17M +$2M +29,708 +917%
OAM
89
Oxford Asset Management
United Kingdom
$2.11M +$2.16M +32,145 New
DC
90
Deere & Company
Illinois
$1.99M -$258K -3,830 -11%
AG
91
Algert Global
California
$1.97M +$779K +11,566 +63%
UBS Group
92
UBS Group
Switzerland
$1.88M +$802K +11,912 +71%
OSAM
93
O'Shaughnessy Asset Management
Connecticut
$1.87M +$1.73M +25,677 +935%
Wells Fargo
94
Wells Fargo
California
$1.85M -$1.53M -22,703 -45%
ZIM
95
Zacks Investment Management
Illinois
$1.78M +$222K +3,293 +14%
SCA
96
Secor Capital Advisors
New York
$1.78M +$1.39M +20,600 +317%
Comerica Bank
97
Comerica Bank
Texas
$1.77M +$324K +4,806 +19%
CIP
98
Convergence Investment Partners
Florida
$1.74M
SIM
99
Spark Investment Management
New York
$1.74M +$1.78M +26,400 New
SFM
100
Systematic Financial Management
New Jersey
$1.73M -$23.2K -345 -1%

MGLN Hedge Fund Activity: Q2 2016 in Review

204 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Magellan Health Services, Inc. (MGLN) for Q2 2016, worth a combined $1.53B — down 3.6% from $1.59B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new MGLN positions and 12 closed out — a net gain of 14 holders — while 83 added to existing stakes and 67 trimmed.

The largest buyer was Arrowstreet Capital, adding an estimated $10.1M. The largest seller was OrbiMed, cutting an estimated $55.1M.

  • 204 institutional investors held Magellan Health Services, Inc. (MGLN) as of Q2 2016, up from 191 in Q1 2016.
  • Funds reported $1.53B of Magellan Health Services, Inc. stock for Q2 2016, down 3.6% quarter-over-quarter.
  • 26 funds opened new Magellan Health Services, Inc. positions in Q2 2016 and 12 closed out, a net change of +14 holders.
  • The largest Magellan Health Services, Inc. buyer in Q2 2016 was Arrowstreet Capital, an estimated $10.1M added.
  • The largest Magellan Health Services, Inc. seller in Q2 2016 was OrbiMed, an estimated $55.1M sold.

Based on aggregated 13F filings for Q2 2016.